FourWorld Capital Management »

Exagen shares owned by FourWorld Capital Management

Quarter-by-quarter ownership of Exagen (XGN) shares owned by FourWorld Capital Management from 13F filings

Historical chart of FourWorld Capital Management investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by FourWorld Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by FourWorld Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.5M 227k 10.99
2025-06-30 $1.5M 209k 6.98

More positions owned by FourWorld Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Evolv Technologies Hldngs In Com Cl A (EVLV)
Seritage Growth Pptys Cl A (SRG)
Arbutus Biopharma (ABUS)
Bristol Myers Squibb (BMY)
Airsculpt Technologies (AIRS)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Exagen (XGN)
Taskus Class A Com (TASK)
Solid Power Class A Com (SLDP)
Neuronetics (STIM)
Zeekr Intelligent Technology Spon Ads (ZK)
Oncology Institu (TOI)
CVRX (CVRX)
Energy Services of America (ESOA)

View all positions for FourWorld Capital Management

Top funds holding Exagen

Rtw Investments
Vanguard Group
Balyasny Asset Management
Invesco
Kennedy Capital Management
Morgan Stanley
Silvercrest Asset Management Group
Wexford Capital
Millennium Management
Two Sigma Investments
Russell Investments
FourWorld Capital Management
Susquehanna International
Manatuck Hill Partners
Geode Capital Management

View all funds holding Exagen